Agree Phoban - no worrys for MSB..and in relation the articles reference to ethical issues - as I read it , this relates to a particular type of Adult Stem Cell being 'induced pluripotent stem cells' (iPS cells).
iPS cells(transformed through the transfection of various genes)are capable of being transformed into cells having the pluripotency of embryonic stem cells.
MPC's have no such issue as they are derived from bone marrow...and MSB are developing data which show MPC's are JUST as compatible as iPS cells (can be reprogrammed) with no safety issues (to date +100 patients).
For more info - see page 64 Bells Botter MSB report ( Aug 11)
GO the Blaster !!
the next mesoblast, page-4
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |